Thromboprophylaxis after knee arthroscopy and lower-leg casting

New England Journal of Medicine

Volumn 376, Issue 6, 2017, Pages 515-525

  Van Adrichem, Raymond A ^a   Nemeth, Banne ^a   Algra, Ale ^a,b   Le Cessie, Saskia ^a   Rosendaal, Frits R ^a   Schipper, Inger B ^a   Nelissen, Rob G H H ^a   Cannegieter, Suzanne C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; ANTICOAGULANT AGENT;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; IMMOBILIZATION; INTENTION TO TREAT ANALYSIS; KNEE ARTHROSCOPY; LOWER LEG CASTING; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; ORTHOPEDIC CAST; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SINGLE BLIND PROCEDURE; THROMBOSIS PREVENTION; TREATMENT DURATION; VENOUS THROMBOEMBOLISM; ADVERSE EFFECTS; ARTHROSCOPY; CHEMICALLY INDUCED; CLINICAL TRIAL; DIAGNOSTIC IMAGING; INCIDENCE; KNEE; LEG; MIDDLE AGED; PLASTER CAST; SURGERY;

ADULT; ANTICOAGULANTS; ARTHROSCOPY; CASTS, SURGICAL; FEMALE; HEMORRHAGE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INCIDENCE; KNEE JOINT; LEG; MALE; MIDDLE AGED; SINGLE-BLIND METHOD; VENOUS THROMBOEMBOLISM;

EID: 85012848319     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1613303     Document Type: Article

References (33)

1. van Adrichem RA, Nelissen RG, Schipper IB, Rosendaal FR, Cannegieter SC. Risk of venous thrombosis after arthroscopy of the knee: Results from a large population- based case-control study. J Thromb Haemost 2015; 13: 1441-8.
2. van Adrichem RA, Debeij J, Nelissen RG, Schipper IB, Rosendaal FR, Cannegieter SC. Below-knee cast immobilization and the risk of venous thrombosis: Results from a large population-based case-control study. J Thromb Haemost 2014; 12: 1461-9.
3. Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrom J. Incidence and mortality of venous thrombosis: A population-based study. J Thromb Haemost 2007; 5: 692-9.
4. ISTH Steering Committee for World Thrombosis Day. Thrombosis: A major contributor to the global disease burden. J Thromb Haemost 2014; 12: 1580-90.
5. Ashrani AA, Heit JA. Incidence and cost burden of post-Thrombotic syndrome. J Thromb Thrombolysis 2009; 28: 465-76.
6. American Academy of Orthopaedic Surgeons. Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty (http://www.orthoguidelines.org/guideline-detail?id=1075).
7. Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines. Chest 2012; 141(2 Suppl): E278S-e325S.
8. National Institute for Health and Care Excellence. Venous thromboembolism: Reducing the risk for patients in hospital. NICE guideline CG92. 2010 (https://www.nice.org.uk/guidance/cg92).
9. American Academy of Orthopaedic Surgeons. Knee arthroscopy (http://orthoinfo.aaos.org/topic.cfm?topic=a00299).
10. Jorgensen PS, Warming T, Hansen K, et al. Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast: A venografic controlled study. Thromb Res 2002; 105: 477-80.
11. Kock HJ, Schmit-Neuerburg KP, Hanke J, Rudofsky G, Hirche H. Thromboprophylaxis with low-molecular-weight heparin in outpatients with plaster-cast immobilisation of the leg. Lancet 1995; 346: 459-61.
12. Lapidus LJ, Ponzer S, Elvin A, et al. Prolonged thromboprophylaxis with Dalteparin during immobilization after ankle fracture surgery: A randomized placebocontrolled, double-blind study. Acta Orthop 2007; 78: 528-35.
13. Lassen MR, Borris LC, Nakov RL. Use of the low-molecular-weight heparin reviparin to prevent deep-vein thrombosis after leg injury requiring immobilization. N Engl J Med 2002; 347: 726-30.
14. ProMISe (Project Manager Internet Server). About ProMISe (https://www.msbi.nl/promise).
15. Schulman S, Angeras U, Bergqvist D, Eriksson B, Lassen MR, Fisher W. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. J Thromb Haemost 2010; 8: 202-4.
16. Ramos J, Perrotta C, Badariotti G, Berenstein G. Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy. Cochrane Database Syst Rev 2008; 4: CD005259.
17. Camporese G, Bernardi E, Prandoni P, et al. Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: A randomized trial. Ann Intern Med 2008; 149: 73-82.
18. Testroote M, Stigter W, de Visser DC, Janzing H. Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-leg immobilization. Cochrane Database Syst Rev 2008; 4: CD006681.
19. Comp PC, Spiro TE, Friedman RJ, et al. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. J Bone Joint Surg Am 2001; 83-A: 336-45.
20. Lassen MR, Borris LC, Anderson BS, et al. Efficacy and safety of prolonged thromboprophylaxis with a low molecular weight heparin (dalteparin) after total hip arthroplasty -The Danish Prolonged Prophylaxis (DaPP) Study. Thromb Res 1998; 89: 281-7.
21. Sobieraj DM, Lee S, Coleman CI, et al. Prolonged versus standard-duration venous thromboprophylaxis in major orthopedic surgery: A systematic review. Ann Intern Med 2012; 156: 720-7.
22. Camporese G, Bernardi E, Noventa F, et al. Efficacy of Rivaroxaban for thromboprophylaxis after Knee Arthroscopy (ERIKA): A phase II, multicentre, doubleblind, placebo-controlled randomised study. Thromb Haemost 2016; 116: 349-55.
23. Nemeth B, van Adrichem RA, Cannegieter SC. The ERIKA trial: still limited evidence on the efficacy of thromboprophylaxis after knee arthroscopy. Thromb Haemost 2016; 116: 1001.
24. Testroote M, Stigter WA, Janssen L, Janzing HM. Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-leg immobilization. Cochrane Database Syst Rev 2014; 4: CD006681.
25. Bushnell BD, Anz AW, Bert JM. Venous thromboembolism in lower extremity arthroscopy. Arthroscopy 2008; 24: 604- 11.
26. Mauck KF, Froehling DA, Daniels PR, et al. Incidence of venous thromboembolism after elective knee arthroscopic surgery: A historical cohort study. J Thromb Haemost 2013; 11: 1279-86.
27. Krych AJ, Sousa PL, Morgan JA, Levy BA, Stuart MJ, Dahm DL. Incidence and risk factor analysis of symptomatic venous thromboembolism after knee arthroscopy. Arthroscopy 2015; 31: 2112-8.
28. Thorlund JB, Juhl CB, Roos EM, Lohmander LS. Arthroscopic surgery for degenerative knee: systematic review and meta-Analysis of benefits and harms. BMJ 2015; 350: h2747.
29. Bergqvist D, Arcelus JI, Felicissimo P, ETHOS investigators. Post-discharge compliance to venous thromboembolism prophylaxis in high-risk orthopaedic surgery: Results from the ETHOS registry. Thromb Haemost 2012; 107: 280-7.
30. Forster R, Stewart M. Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair. Cochrane Database Syst Rev 2016; 3: CD004179.
31. Rosendaal FR. Venous thrombosis: A multicausal disease. Lancet 1999; 353: 1167-73.
32. Nemeth B, van Adrichem RA, van Hylckama Vlieg A, et al. Venous thrombosis risk after cast immobilization of the lower extremity: derivation and validation of a clinical prediction score, L-TRiP(cast), in three population-based case-control studies. PLoS Med 2015; 12(11): E1001899.
33. Nemeth B, van Adrichem RA, le Cessie S, et al. Prediction of venous thrombosis risk after arthroscopy of the knee. Presented at the International Society on Thrombosis and Haemostasis 2015 Congress, Toronto, June 20-25, 2015 (poster).